Page last updated: 2024-11-03

riluzole and HIV Coinfection

riluzole has been researched along with HIV Coinfection in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"Riluzole is able to increase (effective dose from 1 to 1000 nM) the cell-survival of T cells from HIV-1-infected patients and inhibit spontaneous apoptosis."1.35Enhanced endogenous type I interferon cell-driven survival and inhibition of spontaneous apoptosis by Riluzole. ( Achour, A; Biquard, JM; M'Bika, JP, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achour, A1
M'Bika, JP1
Biquard, JM1
Cachia, D1
Izzy, S1
Ionete, C1
Salameh, J1

Other Studies

2 other studies available for riluzole and HIV Coinfection

ArticleYear
Enhanced endogenous type I interferon cell-driven survival and inhibition of spontaneous apoptosis by Riluzole.
    Virology, 2009, Mar-30, Volume: 386, Issue:1

    Topics: Apoptosis; Cell Survival; HIV Infections; Humans; Immunologic Factors; Interferon Type I; Riluzole;

2009
Brachial amyotrophic diplegia in the setting of complete HIV viral load suppression.
    BMJ case reports, 2012, Dec-06, Volume: 2012

    Topics: Antiretroviral Therapy, Highly Active; Arm; HIV Infections; Humans; Male; Middle Aged; Muscle Weakne

2012